AEye, Inc.LIDRNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P29
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-14.96%
2024-37.38%
2023-30.48%
202241.82%
202154.95%
2020-8.20%
20190.00%
20180.00%